F.D.A.’s Approval of a Drug for Autism Upends Review Process​

F.D.A.’s Approval of a Drug for Autism Upends Review Process​

F.D.A.’s Approval of a Drug for Autism Upends Review Process​

 The agency expanded use of an old drug as a treatment for some people with autism. The endorsement sent some customers scrambling to buy over-the-counter supplements with the same ingredients.  

Creator: The New York Times (NYTHealth)

Related Posts

From Simple Observations to Systems Thinking Health
Veterinary Medicine Impact
Major One Health Conferences to Attend in February 2026
One Health Conferences February 2026
Strengthening Epidemic Readiness Systems for Safer Futures
Epidemic Readiness Systems

Most Recent

Spheres of Focus

Infectious Diseases

Climate & Disasters

Food &
Water

Natural
Resources

Built
Environments

Technology & Data

Featured Posts